NBGI Private Equity

NBGI Private Equity - Ventures

Sound judgement and commercial insight drawing on our own management experience in a wide variety of businesses.

Current Investments

We invest in innovative medical technology companies regardless of stage of development, ranging from pre-prototype to significantly revenue generating. Our investments range from under €1million to €10million per company.

Current Investments
Company Type Stage*
2010 Perfect Vision
Ophthalmology Commercial Development
Advanced Cardiac Therapeutics
Cardiovascular
Prototype
BiospaceMed Imaging Commercial Development
BoneSupport
Orthopedic
Clinical Trials
Estech
Cardiovascular
Commercial Growth
Forth Photonics
Imaging
Pre-prototype
Quanta Fluid Solutions
Renal dialysis
Prototype
Reverse Medical
Cardiovascular Pre-prototype
SuperSonic Imagine
Imaging
Pre-prototype
Upfront Chromatography
Biochemistry
Commercial Development

* Stage of company at our first investment

See our realised investments

Biospace Med

Biospace Med has developed the EOS device, a novel 3D digital x-ray imaging system.

Type:
Imaging
Stage:
Commercial Development
Country:
France

Find out more about Biospace Med

Reverse Medical

Reverse Medical develops novel systems for use in carotid artery stenting and neurovascular applications.

Type:
Cardiovascular
Stage:
Pre-prototype
Country:
USA

Find out more about Reverse Medical

2010 Perfect Vision

20/10 Perfect Vision® has developed a highly innovative surgical laser system offering a variety of novel applications.

Type:
Ophthalmology
Stage:
Commercial Development
Country:
Germany

Find out more about 2010 Perfect Vision

Bone Support

BoneSupport develops innovative products addressing various spine conditions.

Type:
Orthopedic
Stage:
Clinical Trials
Country:
Sweden

Find out more about Bone Suppport

SuperSonic Imagine

SuperSonic Imagine has developed an ultrasound system with an innovative medical platform that can measure and visualize tissue elasticity.

Type:
Imaging
Stage:
Pre-prototype
Country:
France

Find out more about SuperSonic Imagine

Upfront Chromatography

Upfront has developed a unique chromatographic process based on Expanded Bed Adsorption (EBA).

Type:
Biochemistry
Stage:
Commercial Development
Country:
Denmark

Find out more about Upfront Chromatography

Forth Photonics

Forth Photonics has developed an innovative device for the non-invasive, early and accurate detection of cervical cancer.

Type:
Imaging
Stage:
Pre-prototype
Country:
UK

Find out more about Forth Photonics

Estech

Estech has developed an innovative range of products for minimally invasive cardiac surgery procedures.

Type:
Cardiovascular
Stage:
Commercial Growth
Country:
USA

Find out more about Estech

Quanta Fluid Solutions

Developing a portable system for home hemodialysis.

Type:
Renal dialysis
Stage:
Prototype
Country:
UK

Find out more about Quanta Fluid Solutions

Advanced Cardiac Therapeutics

ACT is developing an innovative irrigated cardiac catheter ablation system.

Type:
Cardiovascular
Stage:
Prototype
Country:
USA

Find out more about Advanced Cardiac Therapeutics